Lipid metabolism and lipid signalling molecules are excellent targets for therapeutic intervention, as evident in the fact that many of the most successful therapeutics target lipid metabolism, e.g. statins, non-steroidal anti-inflammatory drugs, and Fingolimod (used to treat multiple sclerosis).
Highlights of our recent research include (1) Identifying the sphingosine 1-phosphate receptors as a good target for new Alzheimer’s Disease therapeutics; and (2) Developing the world’s first potent and specific inhibitor of the enzyme ceramide synthase 1, which we have used to demonstrate a major role for this enzyme in the control of fat storage vs its use as an energy source.
Associate Professor Anthony Don, Sydney Medical School
Phone: (02) 8627 5578
PhD, University of New South Wales, Sydney, 2004
Postdoctoral Fellow, Scripps Research Institute, USA, 2004-2008
Research Fellow, University of New South Wales, Sydney, 2009-2012
Senior Research Fellow, University of New South Wales, Sydney, 2013-2016
>> View Publications Online
- Jonathan Teo, Research Fellow
- Jasmine Khor, Research Assistant
- Oana Marian, PhD student
- Jun Yup Lee, PhD student
- Lisa Shi, PhD student